Novelix Pharmaceuticals Ltd.

Financial

	Novelix Pharma	Sattva Sukun Lifecar	Ecofinity Atomix
Operational Metrics
Financials
5 yr Average ROE	-17.5 %	1.9 %	-0.02 %
5yr average Equity Multiplier	1.26	1.1	3.13
5yr Average Asset Turnover Ratio	0.84	0.19	0.6
5yr Avg Net Profit Margin	-14.11 %	11.99 %	-27.47 %
Price to Book	3.61	1.12	6.59
P/E	130.43	12.08	28.13
5yr Avg Cash Conversion Cycle	29.1 Days	521.98 Days	106.94 Days
Inventory Days	34.04 Days	160.86 Days	11.61 Days
Days Receivable	55.38 Days	410.52 Days	117.32 Days
Days Payable	55.7 Days	135.72 Days	258.61 Days
5yr Average Interest Coverage Ratio	-17.77	19.71	144.8
5yr Avg ROCE	-15.4 %	3.15 %	1.51 %
5yr Avg Operating Profit Margin	-16.49 %	-31124.21 %	-43.96 %
5 yr average Debt to Equity	0.05	0.01	0.49
5yr CAGR Net Profit	35.78 %	n/a	n/a
5yr Average Return on Assets	-13.36 %	1.79 %	-0.74 %
Shareholdings
Promoter Holding	66.56 %	3.62 %	0.82 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.36 %	-11.36 %	-63.72 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0